Morepen Laboratories Ltd MOREPENLAB

Morningstar Rating
₹122.22 −5.61 (4.39%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MOREPENLAB is trading within a range we consider fairly valued.
Price
₹122.22
Fair Value
LOCK|#.xKQ$K&@
Uncertainty
LOCK|>@k
1-Star Price
LOCK|D.JjqYfx
5-Star Price
LOCK|.!@GbVF
Economic Moat
LOCK|VTs
Capital Allocation
—

Trading Information

Previous Close Price
₹127.83
Day Range
₹121.44–126.80
52-Week Range
₹33.05–150.70
Bid/Ask
₹128.33 / ₹116.11
Shares Outstanding
547.95M
Market Cap
₹66.97B
Volume/Avg
75,037 / 22M

Key Statistics

Price/Earnings (Normalized)
55.77
Price/Sales
3.45
Dividend Yield (Trailing)
0.16%
Dividend Yield (Forward)
0.16%
Dividend Payment Schedule
—
Total Yield
0.16%

Company Profile

Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
3,069

Valuation

Metric
MOREPENLAB
Price/Earnings (Normalized)
55.77
Price/Book Value
5.37
Price/Sales
3.45
Price/Cash Flow
59.96
Price/Earnings
MOREPENLAB

Financial Strength

Metric
MOREPENLAB
Quick Ratio
0.80
Current Ratio
2.37
Interest Coverage
11.39
Quick Ratio
MOREPENLAB

Profitability

Metric
MOREPENLAB
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
MOREPENLAB

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|Lkq^$zzMLOCK|y^V&>$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|$TT!hWjVLOCK|&K@>?$48B
Haleon PLC ADR
HLN
LOCK|qw!dT&LOCK|rS$41B
Zoetis Inc Class A
ZTS
LOCK|K#gcT^JcLOCK|BNR$31B
Viatris Inc
VTRS
LOCK|VvH%DxLOCK|<!$20B
Elanco Animal Health Inc
ELAN
LOCK|zsLOCK|$%!$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|&s?y$%LOCK|<C$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|J$BT<?mLOCK|@?l$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|GbclqQLOCK|vYj<$2B
Perrigo Co PLC
PRGO
LOCK|gBy@LSLOCK|Fn$2B

Sponsor Center